|
Abdel-Rahman,Sherif
Z., Ph.D.
Ahmed,
Mahmoud S., Ph.D. Ammenheuser, Marinel M., Ph.D.
Avery,
Eric N.,M.D.
Baillargeon, Jacques G.
Berenson,
Abbey B., M.D.
Bourne, Nigel, Ph. D.
Breier, Barbara
Campbell,
Gerald A., M.D., Ph.D.
Carlton, Susan
M., Ph.D.
Cass,
Alvah R., M.D.
Chakrabarty, Shilla, Ph.D.
Cheng,
Xiaodong, Ph.D.
Chung,
JinMo, Ph.D.
Cloyd,
Miles W., Ph.D.
Cunningham,
Kathryn A., Ph.D.
Denner,
Larry A., Ph.D. DeWitt, Douglas S., Ph.D.
Dineley, Kelly T., Ph.D.
Gallagher,Joel
P., Ph.D.
Gelman,
Benjamin B.,M.D., Ph.D.
Gilbertson,Scott,Ph.D.
Glenn, Jason E., Ph.D.
Gorenstein,
David G., Ph.D. Haupt, Marilyn S. Holzer, Charles R., ITI, Ph.D.
Huang,
Li-Yen M., Ph.D.
Hulsebosch,
Claire E., Ph.D.
Johnson,Kenneth
M., Ph.D.
Kaphalia,
Bhupendra S., Ph.D.
Kesling,
Gary, Ph.D.
Kurosky,
Alex, Ph.D.
Li, Kui, Ph.D.
Li,
Qian, Ph.D.
Luxon,
Bruce A., Ph.D.
McAdoo,
David J., Ph.D. McNearney, Terry M.D. Milligan, Gregg N., Ph.D.
Moron-Concepcion,
Jose, Ph.D.
Motamedi,
Massoud, Ph.D. Moukaddam, Nidal J., M.D.
Neugebauer,
Volker E., M.D.
Okorodudu,
Anthony 0., Ph.D.
Shinnick-Gallagher,
Patricia, Ph.D. Smith, Eric M, Ph.D. Smith, Karen, Ph.D.
Soto, Claudio
A., Ph.D.
Taglialatela,
Giulio, Ph.D. Vargas, Gracie, Ph.D.
Ward,
Jonathan B., Jr., Ph.D. Ware, David L.,M.D.
Watson,Cheryl,Ph.D.
Weinman, Stephen
A.,M.D., Ph.D.
Willis,
William D., Jr., M.D.,Ph.D. Wu, Zhao (Helen)
Wu,
Ping, M.D., Ph.D.
most recent update:
11/19/2007



Dr. Jose Moron-Concepcion,
Sophie Grimond-Billa, Namita Sinha
|
Center for
Addiction Research -
|
Research Services Announces
Researcher of the Month for October

Jose A. Moron-Concepcion, PhD
Assistant Professor,
Department of Pharmacology and Toxicology
Scientist, Center for Addiction Research
Website:
https://www.utmb.edu/addiction/jose_moronconcepcion.htm
Jose Moron-Concepcion came to UTMB in December 2006
with joint appointments in the Center for Addiction
Research and the Department of Pharmacology and
Toxicology. He has a strong scientific background
and expertise in drug addiction, having received his
PhD in Biochemistry at the Universidad Autonoma de
Barcelona, Spain in 1998, and carried out
postdoctoral training at the National Institute of
Drug Abuse (NIDA) in Baltimore from 1999 to 2000. He
spent 2001 to 2002 as a Visiting Scientist in the
Department of Pharmacology at the University of
Texas Health Science Center at San Antonio before
returning to Barcelona to head the Neurology R&D
Programme at Proteomika S.L. He was an Instructor in
the Department of Pharmacology and Biological
Chemistry, Mount Sinai School of Medicine, New York,
from 2003 to 2006, prior to coming to UTMB. Not one
to rest on his laurels, since arriving at UTMB, his
R03 grant application, “PSD protein expression in
extinction of morphine-dependent conditioned
behavior,” was funded, and he has submitted a second
NIH proposal, and is currently working on a third.
Read more
study on cognitive development By
DR.
karen e.
smith

Karen E. Smith, Ph.D.,
professor in the Departments of Neurology and
Pediatrics and member of the Center for Addiction
Research was quoted in USA Weekend (March 9-11,
2007) in the “Annual Report on Baby Steps.” She is
the lead author of a study with Susan Landry, Ph.D.
and Paul R. Swank, Ph.D. (Children’s Learning
Institute, University of Texas Health Science Center
at Houston) published in Pediatrics in May, 2006,
which showed that very low birth weight babies show
stronger cognitive development when their mothers
were highly responsive to their needs across early
childhood. This was true even when controlling for
maternal responsiveness during school ages. Smith
suggests that parents respond promptly and in a warm
and sensitive manner when their baby offers cues not
only when crying but when showing interest in
objects and activities. Smith is currently
extrapolating knowledge from premature infants and
infants born to drug-abusing mothers to help
accelerate cognitive development.

ASPET-Astellas Awards in
Translational Pharmacology
Kathryn
A. Cunningham, Ph.D., Chauncey Leake Distinguished
Professor of Pharmacology and director of UTMB's
Center for
Addiction Research, has been selected as one of
three ASPET-Astellas award recipients. The
ASPET-Astellas Awards in Translational Pharmacology
recognize pharmacological research accomplishments
that seek to extend fundamental research closer to
applications directed towards improving human
health, and that may offer significant advances in
clinical medicine in the future. Cunningham will
receive the award at the Experimental Biology ’07
meeting in late April, in Washington D.C. |
|